China Medical System (00867.HK) MSCI-ESG Rating Upgraded To AA, Reaching Global Level
Tuesday, 22 December 2020, 4:02 pm Morgan Stanley Capital International (MSCI) issued a report on December 17 upgrading the ESG (Environmental, Social and Governance) Rating for China Medical System Holdings Limited ("China Medical System"), a well-established, innovation-driven specialty pharma with a focus on sales & marketing in China. China Medical System's ESG Rating has been upgraded from "BBB" to "AA", surpassing 88% of companies in the global pharmaceutical industry, symbolizing that the Company has attained a level among its global peers in ESG management. MSCI recognized China Medi...
Source: scoop.co.nz